JPRN-UMIN000002944尚未招募未知
Irbesartan Antihypertensive effect on Kidney and Heart - INAKA study
The University of Tokushima hospital0 个研究点目标入组 200 人开始时间: 2010年1月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Severe Kidny disease
研究者
相似试验
已完成
4 期
Evaluation of renal protection by irbesartan and losartan in renal transplanted patientsrenal transplantationJPRN-UMIN000003359Kanazawa Medical University School of Medicine, Division of Nephrology140
已完成
不适用
The influence of irbesartan on biomarkers of renal function and oxidative stresshypertensionJPRN-UMIN000013065ational Defense Medical College30
进行中（未招募）
1 期
Irbesartan in the treatment of Hypertensive Patients with Metabolic Syndrome.Irbesartan en el tratamiento del paciente hipertenso con síndrome metabólicoHypertension, nosEUCTR2005-000614-12-ESBristol Myers Squibb International Corporation540
进行中（未招募）
不适用
Irbesartan in the treatment of Hypertensive Patients with Metabolic Syndrome.Revised Protocol 2, incorporating Protocol Amendments 01 dated 09-Jan-06 & 02 dated 05-Oct-2006. And Protocol amendment 03 dated 24-Oct-2006 - Biomarkers Substudy.EUCTR2005-000614-12-DEBristol Myers Squibb International Corporation540
进行中（未招募）
不适用
Irbesartan in the treatment of Hypertensive Patients with Metabolic Syndrome.Treatment of hypertensive patients with metabolic syndromeMedDRA version: 6.1Level: HLGTClassification code 10057166EUCTR2005-000614-12-ITBRISTOL-M.SQUIBB540